ALCON ATROPINE SOLUTION

País: Canadá

Língua: inglês

Origem: Health Canada

Ingredientes ativos:

ATROPINE SULFATE

Disponível em:

ALCON CANADA INC

Código ATC:

S01FA01

DCI (Denominação Comum Internacional):

ATROPINE

Dosagem:

1%

Forma farmacêutica:

SOLUTION

Composição:

ATROPINE SULFATE 1%

Via de administração:

OPHTHALMIC

Unidades em pacote:

5 ML

Tipo de prescrição:

Prescription

Área terapêutica:

MYDRIATICS

Resumo do produto:

Active ingredient group (AIG) number: 0104748001; AHFS:

Status de autorização:

APPROVED

Data de autorização:

2017-03-08

Características técnicas

_ _
_ _
_ALCON ATROPINE Prescribing Information _
_Page 1 of 10_
PRESCRIBING INFORMATION
Pr
ALCON ATROPINE
Atropine Sulfate Ophthalmic Solution,
BP
1% w/v
Sterile
Cycloplegic - Mydriatic
Alcon Canada Inc.
2665 Meadowpine Blvd.
Mississauga, ON, Canada L5N 8C7
www.alcon.ca
Date of Revision:
March 30, 2022
Submission
Control No: 257471
_ _
_ALCON ATROPINE Prescribing Information _
_Page 2 of 10_
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
.................................................... 3
SUMMARY PRODUCT INFORMATION
....................................................................3
INDICATIONS AND CLINICAL USE
.........................................................................3
CONTRAINDICATIONS
.............................................................................................3
WARNINGS AND PRECAUTIONS
.............................................................................4
ADVERSE
REACTIONS..............................................................................................5
DRUG INTERACTIONS
..............................................................................................6
DOSAGE AND ADMINISTRATION
...........................................................................6
OVERDOSAGE
...........................................................................................................7
STORAGE AND STABILITY
......................................................................................7
DOSAGE FORMS, COMPOSITION AND PACKAGING
............................................7
PART III: CONSUMER
INFORMATION..........................................................................
8
_ _
_ALCON ATROPINE Prescribing Information _
_Page 3 of 10_
Pr
ALCON ATROPINE
atropine sulfate ophthalmic solution,
BP
PART I: HEALTH PROFESSIONAL INFORMATION
SUMMARY PRODUCT INFORMATION
ROUTE OF
ADMINISTRATION
DOSAGE FORM /
STRENGTH
CLINICALLY RELEVANT NONMEDICINAL
INGREDIENTS
Topical (ophthalmic)
Solution/
1% w/v
Benzalkonium
chloride as preservative.
_For a com